Shanghai, China

Yinggang Tang

This inventor holds 2 USPTO granted patents, plus 1 CIPO patent. Top assignees: Jiangsu Hengrui Medicine Company Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd., Shanghai Senhui Medicine Co., Ltd.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yinggang Tang. Retrieved from https://idiyas.com/inventor/yinggang-tang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yinggang Tang: Innovator in Neurokinin-1 Antagonist Development

Introduction

Yinggang Tang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of neurokinin-1 antagonists. His work focuses on creating compounds that can effectively treat diseases related to the neurokinin-1 receptor.

Latest Patents

Yinggang Tang holds a patent for a neurokinin-1 antagonist, which is represented by a specific formula. This compound, or its pharmaceutically acceptable salt, is designed to avoid hemolytic effects of drugs and reduce the side effects associated with drug administration. The innovation in this patent highlights the potential for improved therapeutic options in treating various medical conditions.

Career Highlights

Throughout his career, Yinggang Tang has worked with prominent companies in the pharmaceutical industry. He has been associated with Shanghai Shengdi Pharmaceutical Co., Ltd and Shanghai Senhui Medicine Co., Ltd. His experience in these organizations has contributed to his expertise in drug development and innovation.

Collaborations

Yinggang Tang has collaborated with notable professionals in his field, including Jian Huang and Lingjian Zhu. These partnerships have likely enhanced his research and development efforts, leading to advancements in pharmaceutical innovations.

Conclusion

Yinggang Tang's contributions to the field of neurokinin-1 antagonists demonstrate his commitment to improving medical treatments. His innovative approach and collaboration with industry professionals position him as a key figure in pharmaceutical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…